首页 | 本学科首页   官方微博 | 高级检索  
检索        

顺铂和替加氟及去甲斑蝥酸钠联合放疗治疗中晚期食管癌的临床研究
引用本文:侯良宝,贾秋龙,刘彦中,王清,梁卫宏.顺铂和替加氟及去甲斑蝥酸钠联合放疗治疗中晚期食管癌的临床研究[J].中国肿瘤临床与康复,2010(2):125-127.
作者姓名:侯良宝  贾秋龙  刘彦中  王清  梁卫宏
作者单位:河南第一荣康医院放疗科;新乡市传染病医院;
摘    要:目的探讨联合化疗提高中晚期食管癌放射治疗的方法。方法186例食管癌患者根据入选标准随机分组,92例进入放射治疗+化疗组(放化组),94例进入单纯放射治疗组(单放组)。化疗方案:替加氟800 mg、去甲斑蝥酸钠20 mg均为第1~5天;顺铂30 mg第1~3天;化疗与放射治疗同步第1、4周进行。放射治疗:60Coγ线照射,先设前后对穿野DT40 Gy/4.0周,结束后成角缩野追加24~28 Gy/2.4~2.8周。结果放化组3,5年生存率分别为22.0%和15.9%;单放组3,5年生存率分别为13.8%和8.8%,两组间5年生存率差异有显著性(P=0.040)。毒副作用以综合组较明显,但患者可以耐受。两组的主要死亡原因是局部复发,两组1,3,5年局部复发率差异有显著性。但放化组死于远地转移及淋巴结转移的病例,与单放组比较差异无显著性(χ2=3.17,P〉0.05)。结论以顺铂、替加氟、去甲斑蝥酸钠联合化疗加放射治疗中晚期食管癌可以提高疗效。虽毒副反应有所增加,但患者均可耐受。

关 键 词:食管肿瘤/放射疗法  食管肿瘤/化学疗法  预后

Clinical study of radiotherapy plus chemotherapy for patients with middle-and advance-stage esophageal carcinoma
HOU Liang-bao,JIA Qiu-long,LIU Yan-zhong,et al.Clinical study of radiotherapy plus chemotherapy for patients with middle-and advance-stage esophageal carcinoma[J].Chinese Journal of Clinical Oncology and Rehabilitation,2010(2):125-127.
Authors:HOU Liang-bao  JIA Qiu-long  LIU Yan-zhong  
Institution:HOU Liang-bao,JIA Qiu-long,LIU Yan-zhong,et al(Department of Radiation Oncology,The First Rong Kang Hospital of Henan Province,Xinxiang 453003,China)
Abstract:Objective To evaluate the efficacy of radiotherapy combined with chemotherapy in treatment of patients with middle-and advanced-stage esophageal cancer.Methods 186 patients with middle-and advanced-stage esophageal cancer were randomized into two groups: 92 treated with radiotherapy combined with chemotherapy(R-C)and 94 with radiotherapy alone(R).The chemotherapy regimen included tegafur 800 mg on d1-d5,injectio natarii norcantharidatis 20 mg on d1-d5,cisplatin 30 mg on dl-d3.When radiotherapy(RT) was start...
Keywords:Esophageal neoplasms/radiotherapy  Esophageal neoplasms/chemotherapy  Prognosis  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号